Buying medical content marketing services without buying risk

Agencies with a verified published price

How to buy medical content without buying a compliance problem

1. Fix the review chain before the first brief. Name the clinician who reviews, the compliance or legal reviewer if you have one, and the person who signs off publication. Agree turnaround times for each. Content programmes in healthcare stall in review far more often than in drafting, and an agency that has not asked about this is quoting a timeline it cannot hold.
2. Substantiate before you publish, not after. The FTC's health products compliance guidance is explicit that claims about health benefits or safety generally require competent and reliable scientific evidence, and that advertising includes websites, social content and influencer marketing. Ask how the agency sources and files evidence for each claim, and who keeps the file.
3. Decide the patient story policy early. Testimonials, before and after imagery and case studies involve identifiable individuals and require documented consent, and in the United States protected health information carries its own rules. Settle what you will and will not publish, and put the consent form in the workflow rather than in an email thread.
4. Separate authorship from attribution. A page bylined by a clinician should reflect that clinician's actual involvement. Decide whether they write, review or are quoted, and describe it accurately on the page. Readers and search engines both reward content that shows real expertise, and a byline that overstates involvement is a claim like any other.

What moves the price

Subject risk moves it first. General wellness content is cheaper to produce than content covering a treatment, a device or an outcome, because the second kind needs evidence gathered, cited and defensible. Review burden moves it second: a programme with a single clinical reviewer runs faster and cheaper than one with clinical, legal and brand review in series, and the difference is measured in weeks per piece rather than in words.

Writer sourcing moves it third and is where quotes diverge most. A generalist content mill and a firm that briefs clinically trained writers will quote per piece figures that look like different products, because they are. Ask for two samples on a subject close to yours and give them to your own clinical reviewer without telling them the source. The redline you get back is the most honest price comparison available.

Questions that separate specialists from generalists

Ask which regulated categories they have worked in and what they refused to publish. A specialist will name a claim they pushed back on; a generalist will say they follow the client's instruction, which means the risk sits with you unreviewed. Ask how they handle a clinician who disagrees with a draft, since the answer reveals whether review is a real gate or a formality.

Then ask about measurement. Healthcare content programmes often take longer to show commercial return than other sectors because the reader's decision is slower and more considered, so a proposal that promises fast lead volume is either describing a different kind of content or has not worked in the category. A credible plan reports on qualified enquiries and on the reviewed publication rate, and says plainly which quarter it expects the first to move.

Questions people actually ask

What makes medical content more expensive than general content?

Evidence and review. Claims about health benefits or safety generally require competent and reliable scientific evidence under the FTC's health products compliance guidance, so each claim has to be sourced and filed, and every piece passes clinical review. That adds hours per article and weeks per programme, and both show up in the price.

Can an agency write in a clinician's name?

Ghostwriting with genuine clinical review is common and defensible. What is not defensible is a byline that implies involvement that did not happen. Decide whether the clinician writes, reviews or is quoted, and describe that accurately on the page.

Do we need consent for patient testimonials?

Yes, documented consent, and in the United States information identifying a patient carries additional legal obligations. Settle the policy before the first brief and keep the consent record with the asset, not in an inbox. An agency that treats this as your problem alone has not worked in the category.

How long before a medical content programme shows return?

Longer than in most sectors, because the reader's decision is slower and the review chain limits publication pace. Judge early months on reviewed pieces published and on the quality of the evidence file, and set the commercial review at least two quarters out.

Browse agencies by specialty

• SEO agencies with verified facts
• PPC agencies with verified facts
• Social media agencies with verified facts
• Content marketing agencies with verified facts
• Email marketing agencies with verified facts
• Performance marketing agencies with verified facts